Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-037171

Options or other derivatives

  • Chief Operating Officer acquired 22,888 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Cittadine Andrew · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-12-02 Grant or award : show line 1 in the form Stock Options +8,969 8,969 D
2025-12-02 Grant or award : show line 2 in the form Restricted Stock Units +13,919 52,593 D
Loading xslF345X05/rdgdoc.xml…